Deciduous Therapeutics

Deciduous

This company develops medicines that activate the immune system to remove senescent cells for patients with age-related metabolic and fibrotic diseases.

Neotis

This company develops immunotherapies targeting senescent cells to treat age-related and fibrotic diseases for patients with chronic conditions.

Rubedo.Life

This company develops small-molecule prodrugs that selectively eliminate senescent cells for patients with age-related chronic diseases and skin conditions.

Cleara Biotech

The company develops peptide-based therapies that target and eliminate senescent cells to treat patients with late-stage cancers and age-related chronic diseases.

Senisca

This company develops oligonucleotide-based therapeutics that reprogramme senescent cells to treat age-related diseases and aesthetic signs of ageing for patients and pharmaceutical partners.

Rubedo

This biopharmaceutical company develops therapeutics targeting senescent cells to treat chronic age-related diseases for patients with skin and pulmonary conditions.

Transquis

This biopharmaceutical company develops small molecule therapeutics that reprogram dysfunctional myeloid immune cells to treat patients with neurodegenerative and aging-related diseases.

Integrated Biosciences

The company develops small-molecule therapies for age-related diseases using a synthetic biology and machine learning platform to target cellular stress responses.